Work

CLORETAZINE™ (VNP40101M) Is Active in Elderly Untreated Poor Risk Patients with Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS).

Year: 2005

Type: article

Source: Blood

DOI: 10.1182/blood.v106.11.2786.2786

Authors: Francis Giles, Susan O’Brien, David Rizzieri, Judith Karp, Maureen Cooper, Ghulam Mufti, Bonny Johnson, Verena Karsten, Norbert Vey

Institutions: The University of Texas MD Anderson Cancer Center, Duke Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, King's College Hospital, Vion Pharmaceuticals (United States), Institut Paoli-Calmettes

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2558660748

FWCI: 0.39

Cites:

Cited by: 2

Related to: 10